JUNO
Juno Therapeutics, Inc.
JUNO
JUNO
Delisted
JUNO was delisted on the 5th of March, 2018.
170 hedge funds and large institutions have $2.63B invested in Juno Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 70 increasing their positions, 39 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
12% more capital invested
Capital invested by funds: $2.34B → $2.63B (+$291M)
8% more funds holding
Funds holding: 158 → 170 (+12)
Holders
170
Holding in Top 10
5
Calls
$52.4M
Puts
$32.5M
Top Buyers
| 1 | +$77.7M | |
| 2 | +$27.2M | |
| 3 | +$18.7M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$18.3M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$18.3M |
Top Sellers
| 1 | -$9.9M | |
| 2 | -$7.46M | |
| 3 | -$6.41M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.58M |
| 5 |
Morgan Stanley
New York
|
-$4.05M |